OTCMKTS:RCDTF - Recordati Industria Chimica e Farmaceutica Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$57.00
+0.30 (1.20%)

This chart shows the closing price for RCDTF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Recordati Industria Chimica e Farmaceutica Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RCDTF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RCDTF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for Recordati Industria Chimica e Farmaceutica in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $57.00.

This chart shows the closing price for RCDTF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 3 investment analysts is to hold stock in Recordati Industria Chimica e Farmaceutica.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/29/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/24/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/23/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
5/22/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/21/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/20/2021Deutsche Bank AktiengesellschaftInitiated CoverageHold
10/30/2020The Goldman Sachs GroupDowngradeBuy ➝ Neutral
8/4/2020Jefferies Financial GroupDowngradeBuy ➝ Hold
(Data available from 6/22/2016 forward)

Recordati Industria Chimica e Farmaceutica

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. is a subsidiary of Fimei - Finanziaria Industriale Mobiliare ed Immobiliare S.P.A.
Read More

Today's Range

Now: $57.00
Low: $57.00
High: $57.00

50 Day Range

MA: $54.44
Low: $53.65
High: $57.00

52 Week Range

Now: $57.00
Low: $51.69
High: $57.00

Volume

N/A

Average Volume

5,160 shs

Market Capitalization

$11.92 billion

P/E Ratio

27.40

Dividend Yield

N/A

Beta

0.29

Frequently Asked Questions

What sell-side analysts currently cover shares of Recordati Industria Chimica e Farmaceutica?

The following equities research analysts have issued research reports on Recordati Industria Chimica e Farmaceutica in the last year: Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., The Goldman Sachs Group, Inc., and Zacks Investment Research.
View the latest analyst ratings for RCDTF.

What is the current price target for Recordati Industria Chimica e Farmaceutica?

0 Wall Street analysts have set twelve-month price targets for Recordati Industria Chimica e Farmaceutica in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Recordati Industria Chimica e Farmaceutica in the next year.
View the latest price targets for RCDTF.

What is the current consensus analyst rating for Recordati Industria Chimica e Farmaceutica?

Recordati Industria Chimica e Farmaceutica currently has 3 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in RCDTF, but not buy more shares or sell existing shares.
View the latest ratings for RCDTF.

What other companies compete with Recordati Industria Chimica e Farmaceutica?

How do I contact Recordati Industria Chimica e Farmaceutica's investor relations team?

Recordati Industria Chimica e Farmaceutica's physical mailing address is Via Matteo Civitali 1, Milano L6, 20148. The company's listed phone number is 390-248-7871 and its investor relations email address is [email protected] The official website for Recordati Industria Chimica e Farmaceutica is www.recordati.com.